Trials / Completed
CompletedNCT02960347
Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Herzog Hospital · Academic / Other
- Sex
- Male
- Age
- 10 Months – 36 Months
- Healthy volunteers
- Not accepted
Summary
The current study examined the feasibility of High-Definition tDCS (HD-tDCS) in reducing epileptiform activity in a 30-month-old child suffering from early onset epileptic encephalopathy. HD-tDCS was administered over 10 intervention days spanning two weeks including pre- and post-intervention video-electroencephalography (EEG) monitoring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High-definition (HD) transcranial direct current stimulator, HD-tDCS with 4x1 HD adaptor | Non-invasive focal neuromodulation |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-05-01
- Completion
- 2016-06-01
- First posted
- 2016-11-09
- Last updated
- 2022-08-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02960347. Inclusion in this directory is not an endorsement.